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Purpose: To investigate whether clinical and neuropsycho-
logical impairment in cerebral small-vessel disease (CSVD)
can be evaluated by means of morphological magnetic res-
onance imaging (MRI).
Materials and Methods: MRI at 3 Tesla in T2- and T1-
weighted sequences was evaluated in 44 patients with ce-
rebral microangiopathy, and 30 patients with combined
cerebral micro- and macroangiopathy. The MR character-
istics were correlated to clinical data, attentional impair-
ment, and the patients’ individual vascular risk factor pro-
files. Fifteen healthy age-matched control subjects
participated in the study to assess MR signal changes in
nonhypertensive elderly subjects.
Results: Patients and normal controls differed significantly
in the extent of MR signal changes. A close relation between
age, obesity, hypertension, and MR signal abnormalities
was evident in all patients. Patients with pure CSVD addi-
tionally showed an association between their MR-defined
severity of disease and their degree of neurological impair-
ment, and their vascular risk score. In contrast, attentional
impairment did not relate to the MR-defined severity of
CSVD.
Conclusion: MR signal changes in CSVD show a close
relationship to some risk factors of individual patients.
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HIGH-RESOLUTION MAGNETIC RESONANCE IMAG-
ING (MRI) has tremendously improved the detection of
morphological brain abnormalities in general, and of
qualitative changes of the brain parenchyma in partic-
ular. These predominantly concern alterations of the
white matter, and promise an improvement in the clin-
ical characterization of neurological diseases associ-
ated with morphological abnormalities in this compart-
ment. Cerebral small-vessel disease (CSVD) is the
common pathological feature of a series of subtypes of
cerebral microangiopathy (1–3). The structural damage
of the deep white matter is due to a perfusion deficit
caused by an undefined mechanism and resulting in a
variety of clinical symptoms, neuropsychological ab-
normalities, and MRI characteristics.
In clinical terms, the co-occurrence of minor stroke
symptoms, such as pure motor or sensory stroke, and a
history of hypertension are suggestive of CSVD. Still,
subclinical neurological and neuropsychological signs
may considerably vary in CSVD. Occasionally they are
mild, and therefore are easily overlooked in everyday
clinical practice, thus obscuring the clinical diagnosis.
The association between the degree of clinical and neu-
ropsychological impairment and imaging characteris-
tics in CSVD has been investigated in several previous
studies (4–7). Unfortunately, a comparison of their re-
sults is hampered by differences in terminology and in
the scales used for grading the severity of MRI signal
changes. For these reasons, MRI has not yet contrib-
uted to a better understanding of the underlying etiol-
ogy and pathology of CSVD, but rather has added to the
diagnostic complexity of this disease. More importantly,
the true grade of tissue alteration remains unclear, in
spite of its precise visualization. To complicate matters
further, MRI has revealed a wide spectrum of age-asso-
ciated brain abnormalities (8), mainly consisting of hy-
perintense foci in the deep and subcortical white mat-
ter, and of signal hyperintensities around the lateral
ventricles. Although it has been suggested that these
MRI abnormalities may contribute to the development
of cognitive impairment, their correlation with neuro-
psychological dysfunction is limited. A threshold be-
yond which such a relation may exist has not yet been
defined. Thus, differentiation between age-related
white matter changes and those related to CSVD is
currently not possible.
This study aimed to set the basis for a more selective
approach towards the clinical significance of white mat-
ter signal changes. For this purpose, we reevaluated
high-resolution MRI on a cohort of 74 patients with
pure CSVD or combined cerebral micro- and macroan-
giopathy, and sought to relate the observed morpholog-
ical abnormalities to individual clinical and neuropsy-
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chological data. It has been argued earlier (9) that the
nature and extent of white matter changes is associated
with the stroke subtype and outcome. Additionally, the
vascular risk profiles of individual patients were com-
pared to the MR abnormalities, to evaluate the hypoth-
esis that the vascular risk profile determines the mor-
phological abnormality (10).
MATERIALS AND METHODS
Selection of Patients and Controls
A total of 74 patients (19 females and 55 males; mean
age: 59.4 8 years) with typical neurological symptom-
atology of CSVD (such as motor stroke, sensory stroke,
atactic hemiparesis, and dysarthria (clumsy hand syn-
drome)) and a history of hypertension were included in
this MR study. The patients were under examination by
the Daycare Clinic of Cognitive Neurology, University of
Leipzig, and received morphological MRI as well as an
extensive clinical investigation. Depending on accom-
panying cerebral macroangiopathy, the patients were
divided into two subgroups for further evaluation:
group A, pure cerebral microangiopathy (N  44); and
group B, combined cerebral micro- and macroangi-
opathy (N  30).
Cerebral microangiopathy was declared when both
the typical neurological symptomatology and white
matter MR signal changes were assessed. Cerebral
macroangiopathy was declared when, according to re-
cently published criteria, territorial or watershed cer-
erbal infarctions were diagnosed on MRI. Patients of
group B were included in the chronic stage of macroan-
giopathy, i.e., the onset of symptoms was 8 months
prior to participation in our study. Additionally, pa-
tients of group B had all been diagnosed with CSVD due
to minor stroke events and had a known history of
hypertension for at least 1 year. The selection of the two
patient groups was chosen to address different issues:
1) the correlation of clinical deficits and MR abnormal-
ities (group A), and 2) the influence of cerebral mac-
roangiopathy on MR abnormalities in CSVD (group B).
A comprehensive clinical examination, including
medical history, physical, and detailed neurological ex-
aminations was performed. The Scandinavian Stroke
Scale (SSS) (11) was applied to assess the degree of
neurological impairment. The scores generally range
from 2 to 58. The lower the score, the more severe are
the neurological deficits; 58 points indicate no neuro-
logical impairment. A vascular risk factor profile was
assessed in each individual patient, including the fol-
lowing categories: smoking status (packs/day), diabe-
tes, arterosclerosis, fat metabolism, obesity (body mass
index (BMI)  30), hypertension, and elevated serum
level of homocystein. According to the amount of risk
factors present in each individual patient, a risk factor
score was calculated ranging from 1 to 7.
At the time of this investigation, CSVD patients ex-
hibited only residual symptoms of their previous neu-
rological complaints. Morphological T2- and T1-
weighted MRI was performed in all patients. Moreover,
15 age-matched control subjects (six females and nine
males; mean age: 59.7  17 years) underwent MRI to
evaluate T2 and T1 MR signal changes in nonhyperten-
sive elderly subjects.
Neuropsychological Assessment
Neuropsychological testing concentrated on evaluating
cognitive deficits in the domain of attention. Attentional
processes were assessed using the subtests Alertness,
Divided Attention, and Go/No-Go from the “test of at-
tentional processes” (TAP) (12). The Alertness test mea-
sures simple reaction times to a briefly presented stim-
ulus (tonic alertness), and thus approximates the
subject’s cognitive information-processing speed. In a
second phase, a warning is presented immediately be-
fore the critical stimulus. Thus, the difference between
reaction times with and without warning can be calcu-
lated (phasic alertness). The Divided Attention test
measures the ability of the subject to react simulta-
neously to visual and auditive stimulus configurations.
The Go/No-Go test serves as a measure of selected
attentional processes. According to abnormal test val-
ues in the three domains—tonic, phasic, and divided
attention—the overall impairment was rated from 0 to 3
degrees of severity, with 0 indicating normal test values
and 3 indicating pathological results in the three atten-
tional subtests.
MRI Protocols
All investigations were performed using a Bruker 3
T/100 Medspec, whole-body system. Signal transmis-
sion and reception were performed using a 28-cm i.d.
quadrature birdcage resonator. Either a whole-body
gradient set (30 mT/m switchable within 500 s) or a
head gradient insert (Magnex: 40 cm i.d., 35 mT/m,
150 s switching time) were employed. Each patient
underwent morphological MRI, using T2- and T1-
weighted sequences in the axial plane.
T1 was performed using a multislice MDEFT se-
quence (13). The special feature of the particular se-
quence used (14) is that a single non-slice-selective
inversion pulse is used to obtain data from a number of
slices, with each resulting image having an identical
contrast and reduced inflow effects. The use of a single
inversion pulse drastically reduces the amount of RF
power required, an important consideration at 3T. The
sequence used here obtained one line of k-space data
from each slice per inversion pulse, using a 10-msec
inversion pulse and 4-msec 90° sinc excitation. Other
parameters were: FOV  250 mm, slice  5 mm, gap 
2 mm, TR  2, TI  650 msec, acquisition matrix 
256  252 reconstructed to 256  256, TE  9.2 msec,
and acquisition bandwidth  20 kHz.
T2 was performed using the rapid acquisition with
relaxation enhancement (RARE) imaging sequence with
the following parameters: geometry as above, matrix 
512  512, acquisition bandwidth  50 kHz, TE  19
msec, effective TE  133 msec, RARE factor  16,
refocusing pulse angle  120° (to reduce the specific
absorption rate (SAR)), and TR  8.5 seconds.
MR Rating Procedure
Because of the lack of a generally accepted score for
quantifying the severity of MR signal changes associ-
ated with CSVD (15), a special score was developed
based on 2D factors. An extended version of the simple
three-point scale for grading white matter lesions in
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anterior and posterior regions of the brain, developed
and tested by van Swieten, et al (16), was employed. The
presence and severity of white matter lesions was
graded according to their extent and uni- or bilateral
distribution on the T2-weighted scan. Vascular lesions,
such as lacunes, were graded by their appearance as a
focal single lesion or as multiple focal lesions, and
multiple confluent lesions. In an extension of the van
Swieten scale, the occurrence of periventricular caps
and rims were graded with one to three points each,
depending on the extent of MR signal changes. Further-
more, the degree of “e´tat crible´” of the basal ganglia was
assessed and graded, depending on unilateral focal,
global, or bilateral involvement. Additionally, brain
stem involvement was graded with one to three points.
As a marker of early CSVD, the appearance of small
hyperintense vessel lines in the periventricular white
matter was evaluated. In addition to its presence on the
T2-weighted scan, the T1 sequence was scanned for the
vessel sign. The visibility of changes on both T2 and T1
indicate a higher degree of morphological impairment.
These are caused by susceptibility gradients around
the vessels and become visible at 3T imaging. The hy-
perintense small vessel sign can be masked fully in
standard clinical MR scanners, especially when lower-
resolution matrices are chosen. Figure 1 visualizes the
typical MR signal changes in CSVD, which were rated in
this study.
MR scoring was performed by two blinded, neurora-
diologically expert investigators. Scores theoretically
Figure 1. Abnormal MR signal changes on the T2-weighted image are the basis of the performed MR staging. (A) Periventricular
caps and rims, and the degree of diffuse white-matter hyperintensities were rated, as well as (B) the severity of basal ganglia
involvement and (C) the presence of lacunar infarcts. The enlargement of perivascular spaces, referred to as (D) the hyperintense
vessel sign, was also evaluated. The hyperintense vessels are marked by white arrows. The applied MR score is based on an
extended three-point scale developed by van Swieten, et al (16). Scores range from 0 to 21; the higher the score, the more MR
abnormalities were assessed.
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range from 0 to 21. The severity of CSVD was assessed
based on the MR score: 6 points  low-degree CSVD,
6–12 points  moderate severity, and 12 points 
severe CSVD. The interobserver agreement (Cohen’s
kappa) was also assessed (17).
Statistical Analysis
Analyses were conducted using computerized statisti-
cal software (version 5.01, SPSS Inc., Chicago, IL). In-
dependent t-tests were used to test differences between
the two patient groups and the normal controls. Nor-
mally distributed data were expressed as mean  stan-
dard deviation. A P-value of 0.05 was considered sta-
tistically significant. To assess the relationship between
clinical data and the spatial distribution and extent of
MR signal changes, bivariate correlation analysis using
Pearson’s coefficient was performed. Age, sex, smoking
status, and other vascular risk factors, as well as base-
line diseases such as hypertension and diabetes, were
introduced as possible dependent variables and related
to the MR signal changes. Moreover, multiple analyses
of variance (ANOVAs) were executed to determine which
parameter or combination of parameters was directly
associated with the MR signal changes. The following
factors were introduced into the ANOVA: 1) the risk
factor profile, 2) the neurological score, and 3) the neu-
ropsychological score. The resulting F values are a mea-
sure of the explained variance to these factors. Calcu-
lation of significance levels yielded the contributors that
had a significant influence on the observed changes.
RESULTS
Clinical and Neuropsychological Characterization
of Patients
Neurological Impairment
At admission, residual neurological deficits, such as
slight motor paresis of the upper or lower limb, su-
pranuclear facial paresis and residual occulomotor dis-
turbances, dysarthria, and residual paraesthesia, were
present in 32 out of 44 patients in group A. Two pa-
tients suffered from limb-kinetic ataxia. SSS scores,
assessed prior to the MR session, ranged from 40 to 58,
indicating no or mild-to-moderate neurological deficits.
The mean score was 49  9. In contrast, all patients of
group B experienced more severe residual symptoms
(even in the chronic stage of macroangiopathy), such as
sensory motor paresis, hemianopia, and aphasia.
Stroke scores were below 45 points in all patients, with
a mean of 39 6, which was significantly different from
the mean score assessed in group A (P  0.05).
Attentional Impairment
Difficulties in learning and retention of newly acquired
information were reported in 54 patients. A further
complaint was the inability to adapt to normal everyday
and family life after discharge from the hospital. Atten-
tional impairment concerned 71.9% of group A pa-
tients, 28.1% had normal test values, 18.8% showed
abnormal scores in one attentional domain, 15.6% were
impaired in two attentional subtests, and 37.5% had
severe problems throughout attentional testing. In
group B, 9.1% of patients had normal attentional test
scores, 31.8 were impaired in one subtest, 22.7 showed
abnormal values in two subtests, and 36.4% had severe
problems throughout attentional testing. The overall
attentional score did not differ significantly between
groups A and B. A significant difference between groups
was found for the subtest Divided Attention (group A:
12.84%  9%; group B: 3.58%  4%, P  0.008).
Vascular Risk Profile
With respect to vascular risk factors, all patients of
group A exhibited chronic hypertension, 27.3% suf-
fered from diabetes mellitus, 40.9% showed a disturbed
fat metabolism (hyperlipidemia), 31.8% suffered from
obesity (BMI  30), 18.2% had elevated homocystein
serum levels, and 29.5% smoked more than one pack
per day. Moreover, 15.9% suffered from peripheral ar-
teriosclerosis, and 63.2% of the patients had more than
one risk factor.
In group B the distribution of risk factors was as
follows: chronic hypertension 97%, diabetes 26.7%,
adipositas 33.3%, hyperhomocysteinemia 10%, hyper-
lipidemia 46.7%, smoking 53.3%, and peripheral ath-
erosclerosis 43.3%. Two or more risk factors were ex-
hibited by 86.7% of the patients. The mean risk factor
profiles of the two patient groups differed significantly
(group A: 3.1  1.3; group B: 4.0  1.6, P  0.02). The
distribution of risk profiles within the two patient
groups is displayed in Figure 2.
Morphological MRI
MRI at 3T, particularly the T2-weighted sequence, al-
lowed the characterization of detailed white-matter ab-
normalities in the group of patients and normal con-
trols. The overall interobserver agreement was high:
92% (N  67) of patients received identical scores from
the independent raters. A kappa coefficient (according
to Cohen) of 0.81 was assessed. No disagreement oc-
curred in the classification of mild microangiopathy. All
Figure 2. Comparative distribution of risk factors in patients
with pure CSVD (group A) and concomitant macroangiopathy
(group B).
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patients who had received different scores were found
in the groups showing moderate and severe MR abnor-
malities. Moreover, assessment of T1 and T2 agreement
of the hypertense vessel sign did not coincide in 10
patients. In the cases that were not rated equally, MRI
scans were reevaluated by both observers for a final
verdict.
In the group of age-matched controls, only a few
white-matter abnormalities were detected, such as
small hyperintense vessel lines in the periventricular
white matter in five subjects and small periventricular
caps in another three subjects. MRI scores ranged be-
tween 0 and 3.
In the patient group, overall MRI scores ranged from
4 (indicating a minor degree of microangiopathic MR
changes) to 18 (indicating severe MR abnormalities).
The occurrence and distribution of MR abnormalities is
summarized in Figure 3. According to the MR rating in
group A, 36.4% had slight CSVD, 52.2% had moderate
CSVD, and 11.4% had severe CSVD. In group B, 26.7%
of patients had slight, 46.7% had moderate, and 26.7%
had severe CSVD according to MR criteria. With respect
to the overall MR score, no significant difference was
found between the two patient groups (P  0.05). How-
ever, controls and patients differed significantly (P 
0.001).
In group A, 52.3% of patients had lacunar infarcts,
and white-matter hyperintensities were seen in
90.9% of patients. Basal ganglia involvement was
present in 87% of patients, while brainstem involve-
ment occurred in 22% of all patients. Basal ganglia
involvement and confluent white-matter hyperinten-
sities were extensively present in patients with high
scores of MR changes, whereas the hyperintense
small vessel sign was seen in 95% of patients and
even appeared with a high three-point score, when
only a few other MR abnormalities were present on
the T2-weighted scan. In 78.5% of cases, the vessel
sign was found on the T1-weighted MR scan (Fig. 3).
Caps and rims were detected, to varying extents, in
88% of all patients.
In group B, lacunar infarctions were diagnosed in
66.7% of patients, and white-matter hyperintensities
were found in 68.7% of patients. Basal ganglia involve-
ment was assessed in 58.7% of patients, and brainstem
involvement was found in 13.5% of patients in group B.
The hyperintense vessel sign received lower rankings in
the group of combined micro- and macroangiopathy as
compared to group A, and was present in 85.6% of
patients on the T2-weighted sequence. In contrast, ap-
pearance of the hypertense vessel sign on T1 was as-
sessed in 57.5% of patients. A significant difference
between patient groups was found with respect to
white-matter hyperintensities: group A had a mean
score of 1.3, while group B showed a mean score of 0.8
(P  0.05, t-test for unpaired samples).
Correlations of MR Signal Changes
and Clinical Data
To address the question of whether the degree of MRI
signal changes can serve as a diagnostic tool for judging
the severity of clinical and neuropsychological deficits
in CSVD, the association between MR scores and vari-
ous other clinical data was examined. The results are
shown in Table 1.
The MR score did show the strongest association with
the severity of CSVD as defined by the neurological
score (r  0.87, P  0.001). Only patients of group A
were included in this analysis (N  44). Statistically
significant close correlations for the entire patient
group (N  74) were found for MR score and age (r 
0.27; P  0.04), MR score and obesity (r  0.34, P 
0.08), and MR score and hypertension (r  0.29, P 
0.02). In contrast, no significant relations were found
between MR abnormalities and the presence of diabe-
tes, elevated homocystein, hyperlipidemia, smoking
status, and peripheral atherosclerosis. No significant
relation was found between morphological impairment
and attentional deficits in the patients (r  –0.38 and
P  0.32, and r  0.14 and P  0.67, respectively). The
results of the correlation analysis performed separately
for the two groups yielded further interesting relations
with respect to group A: the MR-defined severity of
CSVD was associated with the duration of hypertension
and with the vascular risk factor profile. In particular,
enlargement of the perivascular space had a close and
significant relation with the clinical parameter hyper-
tension and duration of hypertension (r  –0.35, P 
0.04). Moreover, visibility of MR signal changes on the
T1 image related to higher severity of disease as defined
by T2-defined criteria in group A (r  0.38, P  0.03).
ANOVA revealed those factors that showed a signifi-
cant relation to the assessed MR signal changes. The
following F values were found in group A: neurological
score (F 3.13, P 0.034), risk factors score (F 2.37,
P  0.095), and neuropsychological score (F  0.4, P 
0.42). Thus, calculation of significance levels identified
only the stroke score as having a significant influence
on the observed MR signal changes. In group B no
significant influence was detected by ANOVA.
Figure 3. Comparative distribution of MR characteristics in
patients with CSVD (group A) and concomitant macroangiopa-
thy (group B), which are the basis of the applied MR rating
scale.
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DISCUSSION
This study focused on MR signal changes related to
CSVD with and without concomitant macroangiopathic
vascular lesions. The MR abnormalities detected in the
patient groups were compared to those in an age-
matched control group. Our first major finding was that
our MR scores clearly allow a differentiation between
patients and normal controls. In the literature, there is
no agreement regarding the clinical relevance of diffuse
white-matter hyperintensities when they occur in el-
derly healthy people (18,19,20). Hyperintense periven-
tricular capping of the frontal and parietal horns, and a
smooth halo of periventricular hyperintensity—as as-
sessed in some of our normal controls—have been
linked to disruption of the ependymal lining, sub-
ependymsl gliosis, and concomitant loss of myelin.
However, larger patchy and confluent hyperintensities
that have been described as indicating more extensive
ischemic damage consistent with advanced CSVD were
absent in our controls. Nonvisibility of the slight abnor-
malities in the control group on the individual T1 image
supports the absence of relevant ischemic damage. As
indicated by low MR ratings scores, the white-matter
changes in our controls were only minor, a finding that
was reported previously for larger cohorts of normal
individuals (4).
We also addressed the question of whether CSVD
with (group A) and without (group B) concomitant mac-
roangiopathy can be differentiated based on the pres-
ence and distribution of MR patterns. Several signifi-
cant differences were found. Group A patients showed
significantly more white-matter hyperintensities and
basal ganglia involvement, as compared to those in
group B. Furthermore, rankings of the hypertense
small vessel sign as a measure of the perivascular space
enlargement were significantly higher in group A than
in group B. The issue of microangiopathic changes in
concomitant macroangiopathy has been addressed pre-
viously (21,22). These authors found significantly
higher scores for periventricular hyperintensity, white-
matter hyperintensity, basal ganglia hyperintensity,
and total subcortical hyperintensity scores in their
group of pure CSVD compared with the group that
exhibited macroangiopathy as well. The enlargement of
the perivascular space was also significantly greater in
their CSVD group than in their macroangiopathic
group. Our results are in accordance with these find-
ings, and seem to reflect differences in the pathogenesis
of infarction between the two groups. Silent subcortical
hyperintensity lesions and enlargement of perivascular
space are useful for distinguishing between white-mat-
ter signal changes resulting from large-vessel disease
and pure CSVD. This may have significant implications
for the management of patients with lacunar infarc-
tions. It suggests that the pathogenesis of lacunar in-
farction is variable and may necessitate additional
screening for accompanying cerebral macroangiopathy.
A further goal of this study was to investigate the
relationship between imaging data and neurological
and attentional impairment, as well as the individual
vascular risk profile. Age, severity of hypertension, and
obesity were significantly related to the MR-defined pa-
thology in all patients. While no other relationship was
found in group B, further significant correlations were
observed in group A. MRI-based CSVD severity signifi-
cantly correlated with the degree of neurological impair-
ment, as assessed by the SSS, and chronic hyperten-
sion and its duration. Thus, we conclude that the
hypertense vessel sign on the T2 image is an appropri-
ate measure of the influence of hypertension even in an
early stage of the disease. A close association between
elevated blood pressure and confluent white-matter hy-
perintensities and their progression was also described
in an earlier follow-up study in patients (23), while a
similar relation between age, blood pressure, and MR-
defined lacunar infarctions was observed in a large co-
hort of elderly normal controls by Shintani and cowork-
ers (5).
We used the presence of T1 hypointensity of white-
matter changes as a further valid measure to differen-
tiate between pathological and age-related morpholog-
ical changes. This phenomenon occurs regardless of
the field strength of the scanner. Hypointense lesions
on conventional T1-weighted MRI within areas of white-
matter damage clearly indicate more extensive tissue
destruction, i.e., lacunar or even larger infarcts. Such
changes have been shown to be almost invariably as-
sociated with pronounced CSVD consisting of lipohya-
linosis and fribrohyalinosis (24).
Attentional impairment assessed by alertness testing
did not correlate with the degree of MR abnormalities.
As attention, and in particular alertness, is a measure
of cognitive processing time, a clear correlation between
attentional parameters and the degree of white-matter
hyperintensities representing loss of fibers and reactive
gliosis would be assumed. However, according to pre-
vious reports (25), no linear worsening of cognitive
functions accompanies the increase of white-matter
changes of CSVD as assessed by T2-weighted MRI. On
the contrary, it was assumed that cognitive impairment
is closely related to the degree of cortical atrophy (6).
However, rating the degree of cortical atrophy was ex-
cluded from our MR rating score. We believe that reli-
able evaluation of cortical atrophy based on MR images
necessitates the additional introduction of cortical seg-
Table 1











Age 0,40 0,45* 0,37*
Scandinavian stroke
score — 0,87** —
Attentional impairment 0,03 0,03 0,01
Vascular risk score 0,25 0,40* 0,14
Hypertension 0,28* 0,46* 0,01
Duration of hypertension 0,25 0,45* 0,07
Diabetes 0,14 0,29 0,05
Homocystein 15 mumol/
liter 0,05 0,23 0,23
Hyperlipidemia 0,11 0,12 0,17
Obesity 0,34* 0,39** 0,18
Smoking status 0,09 0,22 0,05
Peripheral arteriosclerosis 0,14 0,02 0,20
aSignificant correlations: *P  0.05; **P  0.001.
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mentation procedures, and can not be sufficiently per-
formed based on the observers’ visual judgment alone.
In conclusion, MR signal changes in CSVD show a
close relationship with some risk factors of individual
patients. This association is masked when concomitant
macroangiopathy, caused by other etiological cofactors,
is present. The overall proportion of MR signal abnor-
malities, as assessed by T2-image hyperintensity, cor-
relates with the clinical severity of the CSVD and allows
differentiation between CSVD and age-related signal
changes. T1-image hypointensity, on the other hand, is
an appropriate indicator of tissue destruction.
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